This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When discussing heart health, heart attacks and cardiacarrest are two terms that are often mistaken for one another. Understanding the difference between heart attack and cardiacarrest can help in recognizing symptoms, seeking prompt medical care, and even saving lives. What is CardiacArrest?
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronaryarterydisease. years, with 57.1% occurring within 30 days after CABG. Original article: Redfors B et al.
Photo by Cedars-Sinai milla1cf Fri, 03/01/2024 - 08:25 March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict sudden cardiacarrest-a health emergency that in 90% of cases leads to death within minutes.
Out-of-hospital cardiacarrest is a leading cause of death, accounting for ≈50% of all cardiovascular deaths. The cardiac catheterization laboratory plays an important role in the coordinated Chain of Survival for patients with out-of-hospital cardiacarrest. Circulation, Ahead of Print.
While on telemetry monitoring he suffered cardiacarrest and was resuscitated. What ECG finding may have contributed to (or precipitated) the cardiacarrest? A coronary angiogram was done that did not show significant coronaryarterydisease. There are no clear signs of OMI.
Background Out-of-hospital cardiacarrest (OHCA) has a dismal prognosis with overall survival around 10%. Previously, 80% of sudden cardiacarrest have been attributed to coronaryarterydisease. Coronaryarterydisease is now likely in the minority with regard to causes of OHCA.
It usually affects older patients suffering from coronaryarterydisease and cardiomyopathies. In cardiacarrest survivors, ventricular fibrillation (VF) is almost always the arrhythmic disorder identified at the time of the event.
A 60-something woman presented after a witnessed cardiacarrest. This is commonly found after epinephrine for cardiacarrest, but could have been pre-existing and a possible contributing factor to cardiacarrest. Final Diagnosis: CardiacArrest due to Torsades from long QT of unknown etiology.
Background Out-of-hospital cardiacarrest (OHCA) has a poor prognosis. The optimal timing and role of early coronary angiography (CAG) in OHCA patients without ST-segment elevation remains unclear. The goal of this study is to compare an early CAG versus delayed CAG strategy in OHCA patients without ST elevation.
BACKGROUND:There is no specific treatment for sudden cardiacarrest (SCA) manifesting as pulseless electric activity (PEA) and survival rates are low; unlike ventricular fibrillation (VF), which is treatable by defibrillation. Circulation: Arrhythmia and Electrophysiology, Ahead of Print.
A family history of heart disease often indicates that genetic factors might be at play. Common Heart Diseases with Genetic Links CoronaryArteryDisease (CAD): CAD occurs when the arteries supplying blood to the heart become narrowed or blocked.
Introduction The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in extracorporeal cardiopulmonary resuscitation (eCPR) has emerged as a treatment option for selected patients who are experiencing refractory cardiacarrest (CA). Results Out of the 377 patients included in the study, 69 (21%) were female.
Heart Valve Disease If one or more heart valves are not functioning correctly, it can cause blood to flow backward, putting extra pressure on the heart, which may cause it to expand to compensate for the inefficiency. This may result in ischemia (lack of oxygen to the heart muscle), causing parts of the heart to weaken and enlarge.
We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. Patients with coronaryarterydisease were excluded. SMuRF-less patients were more likely to present with cardiacarrest (6.6%
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronaryarterydisease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
24% increased risk of coronaryarterydisease. And pretty much every doctor can recall an event where a patient experienced a suddenly stressful event and had a cardiac event. That event might have been a heart rhythm issue or even a cardiacarrest. These findings have been replicated multiple times.
The ST segment changes are compatible with severe subendocardial ischemia which can be caused by type I MI from ACS or potentially from type II MI (non-obstructive coronaryarterydisease with supply/demand mismatch). The arterial blood gas showed a lactic acidosis with a lactate level of 17mmol/L.
CardiacarrestCardiacarrest is a medical emergency in which the heart stops pumping blood to the body. Electrocardiogram, echocardiogram, and some other tests are done for patients with cardiacarrest. ECG machine can also help diagnose coronaryarterydisease.
AI recognizing cardiacarrests in emergency calls. Recently, hospitals have failed to identify 25% of cases of cardiacarrest. Alternatively, it also helps enhance arrhythmia management with coronaryarterydisease. It improves the prediction model for myocardial scar mass.
I suspect this is Type 2 MI due to prolonged severe hypotension from cardiacarrest. If the arrest had another etiology (such as old scar), and the ST elevation is due to severe shock, then it is a type II STEMI. MINOCA: Myocardial Infarction in the Absence of Obstructive CoronaryArteryDisease).
Studies of patients with coronaryarterydisease who developed arrhythmic storm with episodes of PMVT following MI — show arrhythmias indistinguishable from those reported in this case.
But the full cohort of the CABANA trial did not show a significant reduction in the primary composite end point of death, disabling stroke, serious bleeding or cardiacarrest [7]. The study authors noted that lower than expected event rates and treatment crossovers could have affected the results of the trial. doi: 10.1001/jama.2019.0693.
Diffuse ST depression with ST elevation in aVR: Is this pattern specific for global ischemia due to left main coronaryarterydisease? Incidence of an acute coronary occlusion. Diffuse ST depression with ST elevation in aVR: Is this pattern specific for global ischemia due to left main coronaryarterydisease?
It is apparently fortunate that she had a cardiacarrest; otherwise, her ECG would have been ignored. Hospital Course The patient was taken emergently to the cath lab which did not reveal any significant coronaryarterydisease, but she was noted to have reduced EF consistent with Takotsubo cardiomyopathy.
The highly impactful International Study of Comparative Health Effectiveness With Medical and Invasive Approaches ( ISCHEMIA ) trial investigated the effectiveness of invasive (INV) versus conservative (CON) strategies for managing stable coronaryarterydisease. Original article: Gaudino M et al. EuroIntervention.
They increase the risk of hypertension, coronaryarterydisease, coronary vasospasm, arrhythmias, cardiomyopathy, cardiacarrest, and stroke. Introduction:Cocaine and methamphetamine, stimulants with potent central nervous system effects, are known to be cardiotoxic.
We evaluated the primary outcome (cardiovascular death, myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiacarrest) and other end points, by sex, in 1168 (22.6%) women and 4011 (77.4%) men. Women had less coronaryarterydisease: multivessel in 60.0%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content